4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-012167
INTERIM PRESIDENT AND CEO gave up 2,784 shares (to pay taxes)
- INTERIM PRESIDENT AND CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-05-01 | Option exercise | +9,467 | 1,295,155 | D | ||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-05-01 | Shares withheld for taxes | −2,784 | $1.26 | $3,508 | 1,292,371 | D |
| Derivatives | |||||||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-05-01 | Option exercise · Restricted Stock Units | −9,467 | 113,600 | D | ||
Loading xslF345X05/form4-05032024_040502.xml…